Steffen Pfeuffer - Dissemin

Language
Login

All papers authored by Steffen Pfeuffer

This paper was not found in any repository, but could be made available legally by the author.

2021 Steffen Pfeuffer

ORCID

, Leoni Rolfes, Jana Hackert, Konstanze Kleinschnitz, Tobias Ruck, Heinz Wiendl

ORCID

, Luisa Klotz, Christoph Kleinschnitz, Sven G. Meuth, Refik Pul

Effectiveness and safety of cladribine in MS: Real-world experience from two tertiary centres

Upload

This paper was not found in any repository, but could be made available legally by the author.

2020 Steffen Pfeuffer

ORCID

, Tobias Ruck, Leoni Rolfes, Matthias Pawlowski

ORCID

, Marc Pawlitzki

ORCID

ORCID

, Stjepana Kovac, Sven G. Meuth

ORCID

Patients with a relapsing course of steroid‐responsive encephalopathy associated with autoimmune thyroiditis exhibit persistent intrathecal CD4+ T‐cell activation

Upload

This paper is made freely available by the publisher.

Steffen Pfeuffer

ORCID

, Matthias Pawlowski

ORCID

, Gunther S. Joos, Jens Minnerup, Sven G. Meuth, Rainer Dziewas, Heinz Wiendl

Autoimmunity complicating SARS-CoV-2 infection in selective IgA-deficiency

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

Steffen Pfeuffer

ORCID

, Sven G. Meuth

ORCID

Stem cell transplantation and alemtuzumab – options for “early reprogramming” in multiple sclerosis?

Upload

This paper was not found in any repository, but could be made available legally by the author.

2018 Steffen Pfeuffer

ORCID

, Rene Schmidt, Frederike Anne Straeten, Refik Pul, Christoph Kleinschnitz, Marinus Wieshuber, De-Hyung Lee, Ralf A. Linker, Sebastian Doerck, Vera Straeten, Susanne Windhagen, Marc Pawlitzki, Christoph Aufenberg, Michael Lang, Christian Eienbroeker and 8 other authors

Efficacy and safety of alemtuzumab versus fingolimod in RRMS after natalizumab cessation

Upload

This paper was not found in any repository, but could be made available legally by the author.

Steffen Pfeuffer

ORCID

Sarcoidosis following alemtuzumab treatment: Autoimmunity mediated by T cells and interferon-γ

Upload

Missing publications? Search for publications with a matching author name.